546,640 results on '"Pharmaceuticals and cosmetics industries"'
Search Results
2. THE PSYCHEDELIC PHARMACY: A Paradigm Shift in Mental Health Treatment: After a long hiatus, research in psychedelic medicine is progressing rapidly. With the potential approval of MDMA in the near future, what role will pharmacists play in integrating these new therapies into treatment plans?
3. A Closer Look at Affinity Ligands: A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing
4. Steps Towards Demystifying Risk-Based Decision Making: It is important to understand the differences between risk-based decision making and other decision making in a pharmaceutical quality system
5. Development of Mini-Tablet and Multi-Unit Pellet Systems: Advanced oral dosage forms allow for modulation of controlled- and sustained-release profiles
6. Benefiting from Single-Use Tech Downstream: Increases in efficiencies, flexibility, scalability, and sustainability are impacting adoption
7. Driving Innovation in Nucleic Acid Therapeutics: Innovation in this space depends on strategizing for GMP compliance and market access
8. Cleaning Process Design for Peptide Therapeutics: This article explores a grouping strategy for therapeutic peptides incorporating theoretical and experimental methodology and results to define a practical and scientifically justified cleaning procedure
9. REDENSYL AND OTHER HAIR DENSITY HERO INGREDIENTS
10. Reshaping Dosage Forms: Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed
11. Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil
12. Shining a Light on the Long Shadow of Subjectivity in Quality Risk Management: This article explores the emergence of subjectivity in ICH Q9 (R1)
13. Navigating Pediatric ADHD Medication Shortages: Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply
14. DISPENSING HOPE How Pharmasicts Are Advocationg for Abortion Access: Supreme Court decisions and state-level legislation have made abortion access in some states more complicated than ever before
15. A SHINING EXAMPLE: Skin care is sizzling, with brands from across the category hitting the jackpot with beauty consumers
16. MICROORGANISMS AND THEIR EFFECT ON SKIN
17. Proprietary Cell-Line Development for High-Titer AAV Manufacturing: Proprietary cell lines offer opportunities for achieving high AAV titers
18. Fouling Mechanisms of Filters During the Harvest Development of Monoclonal Antibody Therapeutics with Intensified Upstream Processes--Part 2
19. Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil
20. Shining a Light on the Long Shadow of Subjectivity in Quality Risk Management: This article explores the emergence of subjectivity in ICH Q9 (R1)
21. Milestone Approval to Steady Stream, Gene Editing Revs Up: The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies
22. How can solid format beauty products really take off? Solid shampoos, conditioners and moisturisers have been touted as the green future of beauty, but here's what beauty bars need to succeed, writes Julia Wray
23. Using Tolerance Intervals for Evaluation of Uniformity of Dosage Units Data in Routine Batch Release
24. QbD for Small-Molecule Continuous Process Development: Continuous manufacturing and a quality-by-design development approach are a natural fit
25. Compounding Overview: Primary Considerations for the Workplace: Technical, regulatory, and personnel considerations characterize pharmaceutical compounding
26. European Medicines Agency Viewpoint: Steffen Thirstrup, chief medical officer at the European Medicines Agency, provides insight on regulatory challenges in Europe
27. Compounding Overview: Primary Considerations for the Workplace: Technical, regulatory, and personnel considerations characterize pharmaceutical compounding
28. Using Tolerance Intervals for Evaluation of Uniformity of Dosage Units Data in Routine Batch Release
29. QbD for Small-Molecule Continuous Process Development: Continuous manufacturing and a quality-by-design development approach are a natural fit
30. Increasing mRNA Product Stability with Lyophilization: Developing freeze-drying processes requires patience and deep product and process understanding
31. Health Care Outlook 2024
32. New Therapies Cry Out for New Skills: There are positive indications for future growth
33. Right the First Time: Bioreactor Scale and Design Translation
34. New Therapies Cry Out for New Skills: There are positive indications for future growth
35. Developing an Optimized Risk Assessment Portfolio--The Quality Risk Management Master Plan: A thoughtfully constructed QRM Master Plan translates the strategy and enables a risk-based approach
36. Bridging Gaps and Investing in Change: European bio/pharma companies have no choice but to invest and adapt to the evolving industry needs
37. The Pros and Cons of Adherent Versus Suspension Cell Culture: Both adherent and suspension cell culture approaches have their pros and cons, which must be considered for process development
38. Developing an Optimized Risk Assessment Portfolio--The Quality Risk Management Master Plan: A thoughtfully constructed QRM Master Plan translates the strategy and enables a risk-based approach
39. Managing Raw Material Variability for Autologous Cell Therapies: Preparing for variability and flexible processing are necessary for success
40. NACDS 90TH ANNIVERSARY
41. Selecting Excipients for Enhancing Solubility of Hot-Melt Extrusion Formulations: Matching excipients to API properties is essential
42. Establishing a Framework for Reliable Pharma Labeling: By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling
43. Training for Operational Excellence: The bio/pharmaceutical industry is struggling with the challenge of staffing and training. Solutions may include new technology and managing burnout
44. Selecting Excipients for Enhancing Solubility of Hot-Melt Extrusion Formulations: Matching excipients to API properties is essential
45. Revolutionizing Biomanufacturing: The Digitalization Advantage: Digital transformation allows for smarter and connected biomanufacturing operations
46. CAPTAINS of INDUSTRIAL DESIGN: As industrial interior design modernises with softer elements, Julia Wray looks at the beauty brands tapping this aesthetic
47. THE MANUFACTURERS MASTERING MAKE-UP BRUSHES
48. STYLING POLYMERS FOR THE 'MOB WIFE' HAIR LOOK: Rouah Al-Wakeel explores key ingredients in products to achieve the voluminous 80's hairstyles trending on TikTok
49. How Pharmacists Are Expanding Reproductive Care Access: Drug Topics sat down with Solly Rofie, founder of Birth Control Phormocist, to discuss how phormocists ore well positioned to expand access to reproductive Care
50. How Scope Creep Can Save Health Care: In its ongoing campaign against 'scope creep,' the American Medical Association argued that pharmacists don't receive enough training. Physicians and pharmacists alike disagree
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.